Clinical Trial Update: A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of Aleglitazar on cardiac energetics and function in adults with Type 2 diabetes mellitus and no history of coronary artery …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Aleglitazar (Aleglitazar)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED